文献速递妇科

腹腔镜乙醇硬化治疗卵巢子宫内膜异位囊肿的初步结果

Laparoscopic Ethanol Sclerotherapy for Ovarian Endometriomas: Preliminary Results.
PubMed 文献 · J Minim Invasive Gynecol · 2020-05-05

单中心回顾性研究纳入53例64个直径4-10cm、无恶性嫌疑的卵巢子宫内膜异位囊肿,行腹腔镜抽吸及95%乙醇硬化治疗(注入后留置15分钟)。平均随访31个月,5例(9%)复发,无重大乙醇相关并发症;28例有妊娠意愿者中16例(57%)妊娠。

要点

  • 腹腔镜抽吸联合95%乙醇硬化治疗卵巢子宫内膜异位囊肿复发率低于10%。
  • 无重大乙醇相关并发症,即使双侧囊肿或合并深部子宫内膜异位症者亦然。
  • 有妊娠意愿患者中57%实现妊娠,但需注意样本量有限。

核心结论

  • 腹腔镜抽吸及乙醇硬化治疗卵巢子宫内膜异位囊肿,即使双侧或合并深部子宫内膜异位症,复发率低于10%且无重大并发症。

研究设计与样本

  • 单中心回顾性研究,纳入53例女性共64个直径4-10cm、无恶性嫌疑的子宫内膜异位囊肿,2013年9月至2017年9月行腹腔镜抽吸及95%乙醇硬化治疗。

主要发现

  • 平均年龄32岁(范围19-40岁),平均囊肿直径6cm(范围4-10cm)。
  • 无重大乙醇相关并发症记录,平均随访31个月,5例(9%)复发。
  • 28例有妊娠意愿者中16例(57%)妊娠。

关键数值与推荐

  • 95%乙醇注入囊肿后留置15分钟再移除。
  • 术后均予激素治疗,仅妊娠意愿或出现不良反应者停用。
  • 随访采用超声在3、6、9、12个月及之后每年复查以识别复发。

临床怎么用

  • 对于无恶性嫌疑的卵巢子宫内膜异位囊肿,可考虑腹腔镜抽吸联合95%乙醇硬化作为治疗选择。
  • 术后激素治疗可能作为辅助,但妊娠意愿或不良反应时需停用。

局限性

  • 单中心回顾性设计,样本量有限(53例),随访时间平均31个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: The purpose of this study was to evaluate the laparoscopic aspiration of endometriomas through 95% ethanol sclerotherapy. DESIGN: A single-center, retrospective study. SETTING: Endometriosis outpatient clinic of a tertiary university hospital, gynecology department of Agostino Gemelli University Foundation Polyclinic IRCCS, Rome, Italy. PATIENTS: Fifty-three women with 64 identified endometriomas measuring 4 to 10 cm with no suspected malignancy. INTERVENTIONS: Laparoscopic aspiration and 95% ethanol sclerotherapy of endometriomas were completed in the patients between September 2013 and September 2017. MEASUREMENTS AND MAIN RESULTS: Using standard laparoscopy, the ovarian endometriomas were aspirated and washed to remove all cystic material. A 95% ethanol solution was instilled in the cysts and left for 15 minutes, then removed. The patients were followed by ultrasound at 3, 6, 9, and 12 months, and then annually to identify recurrence. All patients were administered postoperative hormone therapy, suspended only in those desiring pregnancy or experiencing adverse effects. The mean age was 32 years (range 19-40 years), and the mean cyst diameter was 6 cm (range 4-10 cm). Thirteen of the 53 patients (25%) had had previous surgery for endometriomas. Forty-one patients (77%) had associated deep endometriosis, treated during the same laparoscopic procedure. No major ethanol-related complications were recorded. The mean length of follow-up was 31 months. Recurrence of endometriomas was observed in 5 patients (9%). Overall, pregnancy occurred in 16 of 28 patients (57%) desiring pregnancy. CONCLUSION: Laparoscopic aspiration and ethanol sclerotherapy as treatment for endometriomas, even in patients with bilateral endometriomas or with associated deep endometriosis, resulted in <10% recurrence and no major complications.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. De Cicco Nardone A, Carfagna P, De Cicco Nardone C, et al. Laparoscopic Ethanol Sclerotherapy for Ovarian Endometriomas: Preliminary Results. J Minim Invasive Gynecol. 2020. PMID: 32380241. doi:10.1016/j.jmig.2019.09.792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。